CDK8 is a colorectal cancer oncogene that regulates β-catenin activity

Ron Firestein(Dana-Farber Cancer Institute), Adam J. Bass(Dana-Farber Cancer Institute), So Young Kim(Broad Institute), Ian F. Dunn(Dana-Farber Cancer Institute), Serena J. Silver(Broad Institute), Isil Guney(Dana-Farber Cancer Institute), Ellen Freed(Dana-Farber Cancer Institute), Azra H. Ligon, Natalie Vena(Dana-Farber Cancer Institute), Shuji Ogino(Dana-Farber Cancer Institute), Milan G. Chheda(Broad Institute), Pablo Tamayo(Broad Institute), Stephen P. Finn, Yashaswi Shrestha(Broad Institute), Jesse S. Boehm(Broad Institute), Supriya Jain(Dana-Farber Cancer Institute), Emeric F. Bojarski(Dana-Farber Cancer Institute), Craig H. Mermel(Broad Institute), Jordi Barretina(Dana-Farber Cancer Institute), Jennifer A. Chan(Broad Institute), José Baselga(Vall d'Hebron Hospital Universitari), Josep Tabernero(Vall d'Hebron Hospital Universitari), David E. Root(Broad Institute), Charles S. Fuchs(Dana-Farber Cancer Institute), Massimo Loda(Dana-Farber Cancer Institute), Ramesh A. Shivdasani(Dana-Farber Cancer Institute), Matthew Meyerson(Dana-Farber Cancer Institute), William C. Hahn(Dana-Farber Cancer Institute)
Nature
September 1, 2008
Cited by 678Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis